Do Drug-Eluting Stents Influence the Spectrum of Coronary Artery Bypass Surgery?;Beeinflussen Drug-eluting Stents das Spektrum der Koronarchirurgie?

Herz

Volumn 29, Issue 2, 2004, Pages 201-207

  Matschke, Klaus ^a   Tugtekin, Sems Malte ^a   Kappert, Utz ^a   Jung, Friedrich ^b   Park, Jai Wun ^c   Knaut, Michael ^a  

^a University Heart Center Dresden   (Germany)

^b Inst fur Herz und Kreislaufforsch   (Germany)

^c Klinikum Hoyerswerda   (Germany)

Author keywords

Bypass surgery; Coronary artery disease; Coronary stent; Drug eluting

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; EQUIPMENT FAILURE ANALYSIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PACLITAXEL; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 1942488223     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-004-2561-9     Document Type: Review

References (29)

1. Bruckenberger E. Herzbericht 2002 mit Transplantationschirurgie. 15. Bericht der Arbeitsgruppe Krankenhauswesen der Arbeitsgemeinschaft der obersten Landesgesundheitsbehörden der Länder (AOLG).
2. The Bypass Angioplasty Revascularisation Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
3. CABRI Trial Participants. First year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995;346:1179-84.
4. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
5. Diegeler A, Thiele H, Falk V, et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 2002;347:561-6.
6. Drenth DJ, Veeger NJ, Winter JB, et al. A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. J Am Coll Cardiol 2002;40:1955-60.
7. European Coronary Surgery Study Group. Long-term results of a prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-9.
8. FDA Public Health Web Notification, October 29th, 2003 (www.fda.gov/cdrh/mdr).
9. Frömke J. Standardoperationen in der Herzchirurgie. Darmstadt: Steinkopff, 2003:21-3.
10. Gunn J, Cumberland D. Stent coatings and local drug delivery. Eur Heart J 1999;20:1693-700.
11. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease: German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994;331:1037-43.
12. Jung F, Bach R, Mrowietz C, et al. Hemocompatibility of endovascular coronary stents: Wiktor GX. Biomed Tech (Berl) 2001;46:200-6.
13. Jung F, Mrowietz C, Seyfert UT, et al. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions. Clin Hemorheol Microcirc 2003;28:189-99.
14. Khan NE, De Souza A, Mister R, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350:21-8.
15. King SB, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994;331:1044-50.
16. MacGillivray TE, Vlakakes GJ. Patency and the pump - the risks and benefits of off-pump CABG. N Engl J Med 2004;350:2-4.
17. Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
18. Park J-W, Jung F. Stent-Restenose: Mechanismen und therapeutische Strategien. Lengerich: Pabst, 2000.
19. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
20. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol 1993;22:1060-70.
21. Rumsfeld JS, Magid DJ, Plomondon ME, et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol 2003;41:1732-8.
22. Serruys PW, Unger F, Sousa JE, et al., for the Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
23. Silber S. Antiprolerativ beschichtete Stents und intrakoronare Brachytherapie: Gemeinsamkeiten und Unterschiede. Z Kardiol 2002;91:443-7.
24. Sim I, Gupta M, McDonald K, et al. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
25. Stone GW, Ellis SG, Copx DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
26. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-93.
27. Taylor A. Metals. In: Sigwart U, ed. Endoluminal stenting. London: Saunders, 1996:28-33.
28. Tugtekin SM, Matschke K, Knaut M, et al. Der symptomatische Koronarpatient mit pathologischem, operationsbedürftigem Koronarangiogramm. Herz 2000;25:707-10.
29. Yock CA, Boothroyd DB, Owens DK, et al. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med 2003;115:382-9.